Clinical Trial Update: Probiotic Saccharomyces Boulardii for the Prevention of Antibiotic-associated Diarrhoea [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Saccharomyces boulardii for prevention of antibiotic-associated diarrhea was terminated; results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antibiotic-associated Diarrhea
• Clostridioides Difficile Infection

Drugs mentioned

• Saccharomyces boulardii (Saccharomyces boulardii)

Snippet

Sponsor: Bernhard Nocht Institute for Tropical Medicine | Conditions: Antibiotic-associated Diarrhea, Clostridium Difficile | Phase 3 | Status: TERMINATED | Results posted: 2016-07-18